Panacea Biotec Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 60.68 | 96.76 | 98.28 |
| Operating Expense | 67.37 | 89.61 | 88.59 |
| Net Profit | -13.78 | -1.37 | 0.43 |
| Net Profit Margin | -22.71 | -1.42 | 0.44 |
| Earning Per Share | -2.25 | -0.22 | 0.07 |
| EBIDTA | -5.49 | 7.13 | 9.69 |
| Effective Tax Rate | TBA | TBA | 6.60 |
| Particulars | Jun 2024 |
|---|---|
| Revenue | 60.68 |
| Operating Expense | 67.37 |
| Net Profit | -13.78 |
| Net Profit Margin | -22.71 |
| Earning Per Share | -2.25 |
| EBIDTA | -5.49 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 359.60 | 257.07 | 235.50 |
| Operating Expenses Annual | 345.44 | 319.69 | 308.17 |
| Operating Profit Annual | 39.07 | -28.19 | -60.10 |
| Interest Annual | 13.78 | 10.06 | 7.04 |
| Depreciation | 21.07 | 24.48 | 25.95 |
| Net Profit Annual | 3.55 | -87.54 | -93.58 |
| Tax Annual | 0.66 | 24.79 | TBA |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 359.60 |
| Operating Expenses Annual | 345.44 |
| Operating Profit Annual | 39.07 |
| Interest Annual | 13.78 |
| Depreciation | 21.07 |
| Net Profit Annual | 3.55 |
| Tax Annual | 0.66 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 6.01 | 5.33 | 8.66 |
| Cash Flow from Operations | 37.27 | -10.74 | -52.69 |
| Cash Flow from Investing | -51.01 | 2.41 | 39.54 |
| Cash Flow from Financing | 12.82 | 9.01 | 9.83 |
| Cash Flow at the End | 5.09 | 6.01 | 5.33 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 6.01 |
| Cash Flow from Operations | 37.27 |
| Cash Flow from Investing | -51.01 |
| Cash Flow from Financing | 12.82 |
| Cash Flow at the End | 5.09 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 10.86 | -10.97 | -25.52 |
| PBIT Margin (%) | 5 | -20.50 | -36.75 |
| PBT Margin (%) | 4.64 | -18.46 | -31.53 |
| Net PROFIT Margin (%) | 0.99 | -34.05 | -39.74 |
| Return On Networth / Equity (%) | 0.86 | TBA | TBA |
| Return On Networth /Employed (%) | 3.26 | TBA | TBA |
| Return On Assets (%) | 0.76 | -18.05 | -16.69 |
| Total Debt / Equity (X) | 0.32 | 0.24 | 0.16 |
| Asset Turnover Ratio (%) | 0.77 | 0.53 | 0.42 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 10.86 |
| PBIT Margin (%) | 5 |
| PBT Margin (%) | 4.64 |
| Net PROFIT Margin (%) | 0.99 |
| Return On Networth / Equity (%) | 0.86 |
| Return On Networth /Employed (%) | 3.26 |
| Return On Assets (%) | 0.76 |
| Total Debt / Equity (X) | 0.32 |
| Asset Turnover Ratio (%) | 0.77 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 383.00 | 396.74 | 416.15 |
| Total Current Assets Annual | 183.20 | 199.13 | 248.83 |
| Non Current Assets Annual | 570.44 | 518.77 | 473.01 |
| Total Shareholders Funds Annual | 329.14 | 325.65 | 415.09 |
| Total Assets Annual | 753.64 | 723.90 | 761.83 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 383.00 |
| Total Current Assets Annual | 183.20 |
| Non Current Assets Annual | 570.44 |
| Total Shareholders Funds Annual | 329.14 |
| Total Assets Annual | 753.64 |
EPS (INR)
Expected
0.00
Reported
-2.59
Surprise
0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
Sep 2023
EPS beaten by 0.00%
